Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Letter
  • Published:

Antagonism of tolazoline by histamine H2-receptor blockers

Abstract

TOLAZOLINE (2-benzyl-2-imidazoline), a peripheral vasodilator and adrenergic blocking agent used to treat peripheral vascular disease and (formerly) hypertension, has actions similar to those of histamine, including vasodilation, pressor responses in the rabbit and stimulation of intestinal smooth muscle, gastric secretion and the heart. The cardiac stimulation has usually been referred to as sympathomimetic. Tachycardia and gastrointestinal distress are prominent clinical side effects of tolazoline. It has been used in place of histamine as a diagnostic agent for gastric function1,2. The effects of tolazoline on gastric acid secretion and heart rate have, however, not been explained adequately in terms of mechanism or receptor theory. We have now been able to investigate this aspect using two specific H2-receptor antagonists3, burimamide and metiamide. Our results indicate that the actions of tolazoline on sinus rate and gastric acid secretion can be classified as H2-histaminergic. Recognition that tolazoline interacts with specific histamine receptors helps to explain why the drug has so many diverse actions affecting almost every organ in the body.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Similar content being viewed by others

References

  1. Nickerson, M., J. Pharmac. exp. Ther., 95, 54–59 (1949).

    Google Scholar 

  2. Nickerson, M., and Hollenberg, N. K., in Physiological pharmacology (edit. by Root, W. S., and Hofmann, F. G.), 252–254 (Academic, New York, 1967).

    Google Scholar 

  3. Black, J. W., Duncan, W. A. M., Durant, C. J., Ganellin, C. R., and Parsons, M. E., Nature, 236, 385–390 (1972).

    Article  ADS  CAS  Google Scholar 

  4. Ash, A. S. F., and Schild, H. O., Br. J. Pharmac., 27, 427–439 (1966).

    CAS  Google Scholar 

  5. Trendelenburg, U., J. Pharmac. exp. Ther., 130, 450–460 (1960).

    CAS  Google Scholar 

  6. Hughes, M. J., and Coret, I. A., Am. J. Physiol., 223, 1257–1262 (1972).

    CAS  PubMed  Google Scholar 

  7. Parsons, M. E., in Int. Symp. Histamine H2-Receptor Antagonists (edit. by Wood, C. J., and Simkins, M. A.), 207–217 (Smith Kline and French Laboratories Ltd, Welwyn Garden City, Hertfordshire, 1973).

    Google Scholar 

  8. Metzler, C. M., in A brief introduction to nonlinear least squares estimation (Compilation of Symposia Papers), 280 (APhA Academy of Pharmaceutical Sciences, 1970).

    Google Scholar 

  9. Waud, D. R., and Parker, R. B., J. Pharmac. exp. Ther., 177, 13–24 (1971).

    CAS  Google Scholar 

  10. Waud, D. R., Pharmac. Rev., 20, 49–88 (1968).

    CAS  Google Scholar 

  11. Schild, H. O., Br. J. Pharmac., 2, 251–258 (1947).

    CAS  Google Scholar 

  12. Arunlakshana, O., and Schild, H. O., Br. J. Pharmac., 14, 48–58 (1959).

    CAS  Google Scholar 

  13. McNeill, J. H., and Verma, S. C., J. Pharmac. esp. Ther., 188, 180–188 (1974).

    CAS  Google Scholar 

  14. Yellin, T. O., Sperow, J. W., Buck, S. H., and Johnson, E. M., Fedn Proc (in the press).

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

YELLIN, T., SPEROW, J. & BUCK, S. Antagonism of tolazoline by histamine H2-receptor blockers. Nature 253, 561–563 (1975). https://doi.org/10.1038/253561a0

Download citation

  • Received:

  • Revised:

  • Issue Date:

  • DOI: https://doi.org/10.1038/253561a0

This article is cited by

Comments

By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.

Search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing